Dee Sparacio: QI Initiative Reduces Venous Thromboembolism in First-Line Ovarian Cancer Care
Dee Sparacio, Research Advocate, shared a post on X about a recent article by Limor Helpman et al., published in Gynecologic Oncology, adding:
“Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer– A quality improvement project; gyncsm oral anticoagulation QI program successfully decreased VTE events during first-line chemotherapy for OC.”
Title: Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer– A quality improvement project
Authors: Limor Helpman, Dana Josephy, Liat Toderis, Victoria Tkach, Noa Rotem, Daniel Shai, Sonya Bar-Adon, Hadas Heger, Yfat Kadan, Ana Blecher, Orgad Rosenblatt, Itai Yagel, Danielle Mor-Hadar, Keren Levanon, Ronnie Shapira-Frommer, Akram Saad, Smadar Bauer, Sara Apter, Tima Davidson, Aaron Lubetsky, Jacob Korach
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 15, 2026, 16:29Denise Rezende: What Should Clinicians Do When Thrombosis Occurs Despite DOAC Therapy?
-
Aug 15, 2026, 16:20Anoop Singh: When India Became the Key to a Faster Hemophilia A Trial
-
Aug 15, 2026, 16:10Swarup K Chakrabarti: Why the Blood–Brain Barrier Matters for Healthy Aging
-
Aug 15, 2026, 16:00Satya Prakash Yadav: Overcoming Overtreatment in Pediatric Immune Thrombocytopenia
-
Aug 15, 2026, 15:54Clare Craig: Examining Post-Pandemic Healthcare Disruption and Thrombocytopenia Risks
-
Aug 15, 2026, 15:26Exploring Pediatric Pulmonary Infarction and Infarction-Like Injury – Seminars in Thrombosis and Hemostasis
-
Aug 15, 2026, 15:23Flora Peyvandi: Global ISTH-BAT Reference Ranges for Children and Adolescents
-
Aug 15, 2026, 15:13How Social Determinants and Clinical Drivers Impact Hospital Outcomes – RPTH Journal
-
Aug 15, 2026, 14:35Grace S.: Diagnosis and Management of Superficial Cephalic Vein Thrombosis